PE / VC
2000
$85 000 M
New York, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Carlyle AlpInvest is a leading global private equity investor with $89 billion of assets under management as of March 31, 2025.
For 25 years, the team has taken an integrated approach to private markets through primary, secondary, portfolio finance, and co-investment opportunities. With a disciplined investment process and a local presence across Europe, North America, and Asia, the team benefits from a global perspective and is committed to delivering value and innovative solutions for investors.
Carlyle AlpInvest employs more than 230 people in New York, Amsterdam, Hong Kong, London, and Singapore.
Transparency and Disclosures: https://www.carlylealpinvest.com/transparency
AlpInvest Private Equity Investment Management, LLC (“APEIM”) is the investment advisor to Carlyle AlpInvest Private Equity Markets (CAPM) (“the Fund”). Carlyle Global Credit Investment Management, LLC (“CGCIM”) is the sub-advisor to the Fund. APEIM and CGCIM are each registered as an investment adviser with the SEC under the Investment Advisers Act of 1940, as amended. TCG Capital Markets, LLC (“TCG Capital Markets”) is a registered broker-dealer with the SEC and a FINRA member and is the distributor of the Fund. APEIM, CGCIM, and TCG Capital Markets are affiliates and are part of The Carlyle Group (Nasdaq: CG). Registration with the SEC and/or FINRA does not imply a certain level of skill or training.
Industry
Region of investment
AlpInvest Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
AlpInvest Secondaries Program VII
|
Private Equity (PE)
|
Education
Fintech
Healthcare Services
Marketing and Advertising
Media and Entertainment
SaaS
Security
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$9000 M
|
December 2020
|
|
AlpInvest Co-Investment Fund VIII
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Media and Entertainment
SaaS
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$3500 M
|
April 2021
|
|
AlpInvest Co-Investment Fund IX
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Media and Entertainment
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$4100 M
|
June 2025
|